Multiple Dose Study of MK-2828 in Participants With Type 2 Diabetes (MK-2828-003)
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
A Study of Doravirine/Islatravir in Healthy Lactating Females (MK-8591A-061)
- Status
- COMPLETED
- Phase
- PHASE1
Pembrolizumab and Odetiglucan in Liver Predominant Metastatic Colorectal Adenocarcinoma
- Status
- RECRUITING
- Phase
- PHASE2
A Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-010)
- Status
- RECRUITING
- Phase
- PHASE3
A Clinical Study of MK-8527 in Healthy Adult Participants (MK-8527-014)
- Status
- COMPLETED
- Phase
- PHASE1
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
- Status
- RECRUITING
- Phase
- PHASE3
A Study of Enlicitide Decanoate (MK-0616, an Oral PCSK9 Inhibitor) in Children and Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0616-029)
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
A Study of Bomedemstat (MK-3543) in Participants With Mild or Moderate Hepatic Impairment (MK-3543-023)
- Status
- COMPLETED
- Phase
- PHASE1
Substudy 03C: A Study of Combination Therapies in Participants With Renal Cell Carcinoma With Recurrent Disease During or After Anti-PD-(L)1 Therapy (MK-3475-03C/KEYMAKER-U03)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Clinical Study of How Coffee and Tea Affect Enlicitide in Healthy Volunteers (MK-0616-040)
- Status
- COMPLETED
- Phase
- PHASE1
A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)
- Status
- RECRUITING
- Phase
- PHASE3
MK-4646 Multiple Dose Trial in Participants With Human Immunodeficiency Virus Type 1 (HIV-1) (MK-4646-003)
- Status
- COMPLETED
- Phase
- PHASE1
A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
- Status
- RECRUITING
- Phase
- PHASE2
A Clinical Study of MK-8294 in Participants With Advanced Solid Tumors (MK-8294-001)
- Status
- RECRUITING
- Phase
- PHASE1
Neoadjuvant ADT + Darolutamide With Pembrolizumab, Followed by Adjuvant Pembrolizumab in Molecularly Stratified High-Risk Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Clinical Study of MK-8527 in Participants With Mild and Moderate Hepatic Impairment (MK-8527-015)
- Status
- COMPLETED
- Phase
- PHASE1
An Open Label Phase 2 Study of Total Neoadjuvant Therapy (TNT) Consisting of FLOT With Pembrolizumab and Short Radiation for Patients With Locally Advanced Gastroesophageal Junction Adenocarcinoma
- Status
- RECRUITING
- Phase
- PHASE2
ASTRAEA: ReinvigorAting ReSponse To ImmunotheRApy in MEtAstatic TNBC With Combination Myeloid Inhibition and Radiation
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study to Evaluate V181 Dengue Vaccine in Healthy Participants 2 to 17 Years of Age (V181-005/MOBILIZE-1)
- Status
- RECRUITING
- Phase
- PHASE3
Study of Lenvatinib Plus Pembrolizumab in IO Refractory mRCC Patients With Brain Metastases
- Status
- WITHDRAWN
- Phase
- PHASE2